Horton, a fourth-round pick by the Texans in 2023, played in 10 games as a rookie before stepping away from the team in late ...

Patients with a rare blood cancer that has relapsed or become resistant to treatment have shown a high response rate to a ...

The Texans will welcome back defensive lineman Dylan Horton who had his rookie season cut short following a cancer diagnosis.

Endometriosis patient Lara Stevens is calling for the condition to be treated with the same urgency as cancer. The ...

India continues to see a steady rise in the incidence of lymphoma, the most common type of blood cancer. But among all the ...

Lara Stevens says endometriosis is like the cancer she had as a child, with the potential to spread and damage multiple ...

Former Horned Frogs standout, who played in national championship game in 2023, made his NFL season debut on Sunday for ...

A recent study derived from the adverse event reporting system of the Food and Drug Administration (FDA) showed that T-cell non-Hodgkin lymphomas were identified in 17 of 536 reports (3.2% ...

Diagnosed with Stage 4 Hodgkin’s lymphoma as a rookie last season, Horton is in remission. He celebrated an important medical ...

Houston Texans defensive end Dylan Horton was activated from the reserve/non-football injured list Saturday, less than a year after he was diagnosed with late-stage Hodgkin lymphoma ...

AstraZeneca’s supplemental New Drug Application (sNDA) for CALQUENCE® (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously ...

Cambridge: AstraZeneca's supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted and granted ...